Cargando…
Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma
Autores principales: | Liu, Shui, Li, Qiao, Li, Yongzhi, Sheng, Jiyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679682/ https://www.ncbi.nlm.nih.gov/pubmed/38020167 http://dx.doi.org/10.3389/fmed.2023.1325304 |
Ejemplares similares
-
Precision diagnosis of hepatocellular carcinoma
por: Wang, Zhenxiao, et al.
Publicado: (2023) -
Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
por: Wen, Xin, et al.
Publicado: (2020) -
Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma
por: Xu, Yongkang, et al.
Publicado: (2022) -
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018) -
Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma
por: Cui, Dawei, et al.
Publicado: (2021)